Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
PMLiVE
16h
Biogen’s higher dose spinal muscular atrophy regimen accepted for review by EMA/FDA
Biogen has announced that the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Crash at Reagan airport
Los Angeles wildfire updates
FDA upgrades recall
Gets 11 years in prison
Hush money conviction appeal
Lay's potato chips recall
OK school citizenship rule
FAA authorized NJ drones
Denver schools face probe
Senate confirmation hearing
CO military base for ICE use
Security detail revoked
ICC sanctions bill blocked
Inspects nuclear facility
Approved for kidney disease
Cutting corporate workforce
Pilot safe after F-35 crash
Recalls chicken nuggets
Email privacy lawsuit filed
To recall 290K+ vehicles
To lay off 234 workers
NC inmate escapes
Fall behind in reading
1st Latina, Black AZ justice
Record trade deficit in goods
Drops classified docs case
Agrees to settle Trump suit
Pushes for earlier trial
Signs Laken Riley Act
To hold migrants
'The Voice' alum dies at 44
Related topics
Biogen
Food and Drug Administration
European Medicines Agency
Spinal muscular atrophy
Feedback